Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
Facebook    Twitter     Linkedin     RSS     Google+    BLOG    You Tube

Journal of Pharmacogenomics & Pharmacoproteomics

Open Access
ISSN: 2153-0645
French Language  |  English
In Association with

Upcoming Event


Upcoming Special Issues

Special issue entitled: "Omics of Metabolic Disorders" has been edited by

Victor P Andreev
Associate Professor
Department of Psychiatry and Behavioral Sciences
University of Miami Miller School of Medicine
Tel. 305 243 3487
E-mail: VAndreev@med.miami.edu  

Special issue entitled: "Applications of Pharmacogenomics" has been edited by

Jorge Duconge
Department of Pharmaceutical Sciences
University of Puerto Rico
Tel. 787 758 2525
Fax 787 767 2796
E-mail: jorge.duconge@upr.edu

Read More»

About the Journal


The Journal of Pharmacogenomics & Pharmacoproteomics publishes articles on new innovations in the field of personalized medicines. The original research articles or current reviews published under the journal deals with the influence of genetic variations on drug response in patients and viceversa. The journal aims to publish innovations in customized drug discovery using proteome technology. The journal provides an open access platform to publish latest advancements in the field of drug design, drug development and drug delivery.
Journal of Pharmacogenomics & Pharmacoproteomics is an open access and peer reviewed journal includes a wide range of field in its discipline to create a platform for the authors to make their valuable contributions towards the journal and the peer review process promises the publishing of quality, reliable and important articles for the readers and authors of scholarly, academic and scientific field.
The Journal of Pharmacogenomics & Pharmacoproteomics welcomes new innovations including but not limited to the field of drug development, pharmacogenomics, pharmacoproteomics, new discoveries in genomic targets, various drug responses due to genetic polymorphisms, chemogenomics, personalized medicines, drug dosage formulations, drug safety and its efficacy.


  Impact Factor: 1.05*
  Index Copernicus Value: 4.76

  NLM ID: 101575137


Journal of Pharmacogenomics & Pharmacoproteomics uses Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Pharmacogenomics & Pharmacoproteomics or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.

OMICS International organises 300+ Conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Submit manuscript at http://www.editorialmanager.com/omicsgroup/ or send as an email attachment to the Editorial Office at editor.jpp@omicsgroup.us
*Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = X/Y



Recently published articles

What is the Logic behind Treating Some Heart Failure Patients without ACE Inhibitors and Beta-Blockers?

Ebraheem Alskaf, Shadia Ahmed, Donna Barnett, Meg Warriner, Andrew Birchall, Victoria Watt and Abdallah Al-Mohammad

The Pharmacogenetics of Nicotine Dependence and Smoking Cessation Therapies

Martin M Zdanowicz and Patti W Adams

Mutation Analysis of Methylmalonyl CoA Mutase Gene Exon 2 in Egyptian Families: Identification of 25 Novel Allelic Variants

Dina A Ghoraba, Magdy M Mohammed and Osama K Zaki

Pharmacokinetics and Safety of Sublingual Flumazenil (CRLS035) in Healthy Adults (Potential Therapy for Hepatic Encephalopathy)

Saadi T, Kramskay R, Zilberman Peled B, Katz N, Peled N and Baruch Y

Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses

Narayana Komaravelli and Antonella Casola

Meet us at our 300+ Global Events in Pharma, Medicine, Science and Technology

Our 2015 Major destinations:
Conferences By Country USA
USA  USA Spain  Spain
Australia  Australia Canada Canada
UAE  UAE China China
Italy  Italy France France
Germany  Germany India India
UK  UK Malaysia Malaysia
Japan  Japan singapore Singapore
France  Brazil South Africa South Africa
South Korea South Korea
Conferences By City USA
Chicago Valencia Beijing
Florida Alicante Houston
Philadelphia Rome San Antonio
Baltimore Birmingham Abu Dhabi
Boston Lexington Las Vegas
Seattle Atlanta Barcelona
New Orleans Brisbane San Francisco
Bengaluru New Delhi Toronto
Dubai London Hyderabad
Conferences By Subject USA
Medical Pharma Veterinary
Agri, Food & Aqua Genetics Molecular Biology
Physics Health care Neuroscience
Chemistry Immunology Nursing
Clinical Massmedia Physics
Environmental Materials Science Microbiology
EEE Environmental  
Chemical Engineering Business & Management
20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version